It is a crucial building block for this DPP-4 inhibitor, utilized in the treatment of type 2 diabetes. 2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile is a key pharmaceutical intermediate employed to synthesize Trelagliptin Succinate.
2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-Fluorobenzonitrile
| API Name | Trelagliptin |
|---|---|
| CAS No | 865759-24-6 |
| Molecular Formula | C13H9ClFN3O2 |
| Molecular Weight | 293.68 g/mol |
| Synonyms | 2-[(6-chloro-3-methyl-2,4-dioxopyrimidin-1-yl)methyl]-4-fluorobenzonitrile |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
It is a crucial building block for this DPP-4 inhibitor, utilized in the treatment of type 2 diabetes. 2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile is a key pharmaceutical intermediate employed to synthesize Trelagliptin Succinate.
The CAS number of 2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-Fluorobenzonitrile is 865759-24-6.
The molecular formula of 2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-Fluorobenzonitrile is C13H9ClFN3O2.
The listed molecular weight of 2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-Fluorobenzonitrile is 293.68 g/mol.
2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-Fluorobenzonitrile is listed as being used in connection with the following API: Trelagliptin.
The listed synonym or IUPAC name for 2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-Fluorobenzonitrile is 2-[(6-chloro-3-methyl-2,4-dioxopyrimidin-1-yl)methyl]-4-fluorobenzonitrile.